USD 0.39
(-3.52%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 1.00 USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 1.00 USD | 0.0% |
2018 | 1.00 USD | 0.0% |
2017 | 1.00 USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 1000.00 USD | -99.62% |
2014 | 266.02 Thousand USD | 48.87% |
2013 | 178.69 Thousand USD | 223.04% |
2012 | 55.31 Thousand USD | 8.09% |
2011 | 51.17 Thousand USD | 12.54% |
2010 | 45.47 Thousand USD | 18.46% |
2009 | 38.38 Thousand USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | -100.0% |
1997 | 100 Thousand USD | -50.0% |
1996 | 200 Thousand USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | 1.00 USD | 0.0% |
2023 Q3 | - USD | -100.0% |
2023 FY | - USD | -100.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2022 Q3 | - USD | -100.0% |
2022 FY | 1.00 USD | 0.0% |
2022 Q2 | 1.00 USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q4 | 1.00 USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | 1.00 USD | 0.0% |
2021 Q4 | - USD | -100.0% |
2021 Q3 | 1.00 USD | 0.0% |
2021 Q2 | - USD | -100.0% |
2020 FY | - USD | -100.0% |
2020 Q3 | 1.00 USD | 0.0% |
2020 Q2 | - USD | -100.0% |
2020 Q1 | 1.00 USD | 0.0% |
2020 Q4 | - USD | -100.0% |
2019 Q3 | - USD | -100.0% |
2019 Q4 | 1.00 USD | 0.0% |
2019 Q2 | 1.00 USD | 0.0% |
2019 FY | 1.00 USD | 0.0% |
2019 Q1 | 1.00 USD | 0.0% |
2018 Q2 | 1.00 USD | 0.0% |
2018 Q4 | 1.00 USD | 0.0% |
2018 Q3 | - USD | -100.0% |
2018 Q1 | 1.00 USD | 0.0% |
2018 FY | 1.00 USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | 5.1 Million USD | 0.0% |
2017 Q3 | - USD | -100.0% |
2017 Q4 | 1.00 USD | 0.0% |
2017 FY | 1.00 USD | 0.0% |
2016 Q2 | 1.00 USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q1 | - USD | -100.0% |
2016 Q3 | - USD | -100.0% |
2016 Q4 | - USD | 0.0% |
2015 Q4 | 1000.00 USD | -99.62% |
2015 FY | 1000.00 USD | -99.62% |
2015 Q1 | 299.3 Thousand USD | 12.51% |
2015 Q2 | 297 Thousand USD | -0.77% |
2015 Q3 | 260 Thousand USD | -12.46% |
2014 Q3 | 253.56 Thousand USD | -1.69% |
2014 FY | 266.02 Thousand USD | 48.87% |
2014 Q2 | 257.92 Thousand USD | 9.02% |
2014 Q1 | 236.58 Thousand USD | 32.4% |
2014 Q4 | 266.02 Thousand USD | 4.91% |
2013 Q4 | 178.69 Thousand USD | 192.31% |
2013 Q1 | 52.33 Thousand USD | -5.39% |
2013 Q2 | 64.74 Thousand USD | 23.71% |
2013 FY | 178.69 Thousand USD | 223.04% |
2013 Q3 | 61.13 Thousand USD | -5.58% |
2012 Q2 | 55.01 Thousand USD | 0.28% |
2012 Q4 | 55.31 Thousand USD | -2.9% |
2012 Q1 | 54.86 Thousand USD | 7.21% |
2012 FY | 55.31 Thousand USD | 8.09% |
2012 Q3 | 56.96 Thousand USD | 3.54% |
2011 FY | 51.17 Thousand USD | 12.54% |
2011 Q3 | 61.11 Thousand USD | 7.52% |
2011 Q4 | 51.17 Thousand USD | -16.27% |
2011 Q1 | 70.66 Thousand USD | 55.4% |
2011 Q2 | 56.84 Thousand USD | -19.55% |
2010 Q1 | 56.58 Thousand USD | 47.41% |
2010 FY | 45.47 Thousand USD | 18.46% |
2010 Q4 | 45.47 Thousand USD | -8.1% |
2010 Q3 | 49.47 Thousand USD | 0.0% |
2010 Q2 | 49.47 Thousand USD | -12.56% |
2009 Q4 | 38.38 Thousand USD | 0.0% |
2009 FY | 38.38 Thousand USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 FY | - USD | -100.0% |
1997 Q3 | 100 Thousand USD | 0.0% |
1997 Q4 | - USD | -100.0% |
1997 FY | 100 Thousand USD | -50.0% |
1997 Q1 | 200 Thousand USD | 0.0% |
1997 Q2 | 100 Thousand USD | -50.0% |
1996 Q3 | 200 Thousand USD | 0.0% |
1996 FY | 200 Thousand USD | 0.0% |
1996 Q4 | 200 Thousand USD | 0.0% |
1996 Q2 | 200 Thousand USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AIM ImmunoTech Inc. | -1.18 Million USD | 100.0% |
Ampio Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Armata Pharmaceuticals, Inc. | - USD | NaN% |
Actinium Pharmaceuticals, Inc. | - USD | NaN% |
Azitra, Inc. | -215.21 Thousand USD | 100.0% |
Can-Fite BioPharma Ltd. | - USD | NaN% |
Chromocell Therapeutics Corporation | - USD | NaN% |
Calidi Biotherapeutics, Inc. | - USD | NaN% |
CEL-SCI Corporation | 2.24 Million USD | 100.0% |
iBio, Inc. | - USD | NaN% |
MAIA Biotechnology, Inc. | - USD | NaN% |
Matinas BioPharma Holdings, Inc. | - USD | NaN% |
Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 100.0% |
NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 100.0% |
NanoViricides, Inc. | - USD | NaN% |
Oragenics, Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
Protalix BioTherapeutics, Inc. | 19.04 Million USD | 100.0% |
Palatin Technologies, Inc. | - USD | NaN% |
Scorpius Holdings, Inc. | 909.15 Thousand USD | 100.0% |
Theriva Biologics, Inc. | - USD | NaN% |